Ali M. Elshamsy

Design and Synthesis of New Dihydropyrimidine Derivatives with a Cytotoxic Effect as Dual EGFR/VEGFR-2 Inhibitors

Lamya H. Al-Wahaibi, Ali M. Elshamsy, Taha F. S. Ali et al. · ACS Omega · 2024 · 36 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +10

Synthesis of New Thiazole-Privileged Chalcones as Tubulin Polymerization Inhibitors with Potential Anticancer Activities

Hamada Hashem, Abdelfattah Hassan, Walid M. Abdelmagid et al. · Pharmaceuticals · 2024 · 29 citations · Full text

Medicine, Medicinal Chemistry, Oncology +9

Synthesis, Physicochemical Characterization using a Facile Validated HPLC Quantitation Analysis Method of 4-Chloro-phenylcarbamoyl-methyl Ciprofloxacin and Its Biological Investigations

Mostafa F. Al-Hakkani, Nourhan Ahmed, Alaa A. Abbas et al. · International Journal of Molecular Sciences · 2023 · 25 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +13

Unveiling the Anticancer Potential of a New Ciprofloxacin-Chalcone Hybrid as an Inhibitor of Topoisomerases I & II and Apoptotic Inducer

Doaa Mohamed Elroby Ali, Hossameldin A. Aziz, Stefan Braese et al. · Molecules · 2024 · 19 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +9

Design and synthesis of new dihydropyrimidine/sulphonamide hybrids as promising anti-inflammatory agents via dual mPGES-1/5-LOX inhibition

Lamya H. Al-Wahaibi, Ali M. Elshamsy, Taha F. S. Ali et al. · Frontiers in Chemistry · 2024 · 14 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +15